| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dystroglycan binding | 1.07e-04 | 12 | 26 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 3.71e-04 | 22 | 26 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.14e-04 | 129 | 26 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.70e-04 | 151 | 26 | 3 | GO:0015085 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 1.41e-05 | 5 | 25 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 1.41e-05 | 5 | 25 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 1.41e-05 | 5 | 25 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 1.41e-05 | 5 | 25 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | tRNA 3'-end processing | 3.93e-05 | 8 | 25 | 2 | GO:0042780 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix disassembly | 6.31e-05 | 10 | 25 | 2 | GO:0090091 | |
| GeneOntologyBiologicalProcess | regulation of wound healing, spreading of epidermal cells | 7.71e-05 | 11 | 25 | 2 | GO:1903689 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 7.71e-05 | 11 | 25 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 7.71e-05 | 11 | 25 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 9.24e-05 | 12 | 25 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.27e-04 | 14 | 25 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix assembly | 1.47e-04 | 15 | 25 | 2 | GO:1901203 | |
| GeneOntologyBiologicalProcess | embryonic body morphogenesis | 1.47e-04 | 15 | 25 | 2 | GO:0010172 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.80e-04 | 722 | 25 | 6 | GO:0051606 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 1.84e-04 | 92 | 25 | 3 | GO:1901019 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.22e-04 | 98 | 25 | 3 | GO:0061045 | |
| GeneOntologyBiologicalProcess | RNA 3'-end processing | 2.22e-04 | 98 | 25 | 3 | GO:0031123 | |
| GeneOntologyBiologicalProcess | regulation of gastrulation | 2.64e-04 | 20 | 25 | 2 | GO:0010470 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 2.73e-04 | 493 | 25 | 5 | GO:0010959 | |
| GeneOntologyBiologicalProcess | response to caffeine | 2.92e-04 | 21 | 25 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.17e-04 | 509 | 25 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix disassembly | 4.16e-04 | 25 | 25 | 2 | GO:0010715 | |
| GeneOntologyBiologicalProcess | microtubule anchoring | 4.16e-04 | 25 | 25 | 2 | GO:0034453 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 4.64e-04 | 126 | 25 | 3 | GO:1903035 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of epidermal cells | 5.23e-04 | 28 | 25 | 2 | GO:0035313 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix assembly | 5.61e-04 | 29 | 25 | 2 | GO:1901201 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 5.62e-04 | 577 | 25 | 5 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 5.76e-04 | 323 | 25 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 6.44e-04 | 141 | 25 | 3 | GO:0001952 | |
| GeneOntologyBiologicalProcess | response to muscle activity | 7.73e-04 | 34 | 25 | 2 | GO:0014850 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 7.73e-04 | 34 | 25 | 2 | GO:1903055 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 8.55e-04 | 359 | 25 | 4 | GO:0006874 | |
| GeneOntologyBiologicalProcess | exit from mitosis | 9.15e-04 | 37 | 25 | 2 | GO:0010458 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 9.65e-04 | 38 | 25 | 2 | GO:0007026 | |
| GeneOntologyBiologicalProcess | negative regulation of stress fiber assembly | 1.02e-03 | 39 | 25 | 2 | GO:0051497 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.02e-03 | 1000 | 25 | 6 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.03e-03 | 166 | 25 | 3 | GO:0061041 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.07e-03 | 40 | 25 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.15e-03 | 389 | 25 | 4 | GO:0055074 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 1.18e-03 | 42 | 25 | 2 | GO:0031114 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.18e-03 | 392 | 25 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 1.24e-03 | 43 | 25 | 2 | GO:0001953 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.24e-03 | 43 | 25 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle localization | 1.29e-03 | 44 | 25 | 2 | GO:0040001 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament bundle assembly | 1.35e-03 | 45 | 25 | 2 | GO:0032232 | |
| GeneOntologyBiologicalProcess | epiboly involved in wound healing | 1.41e-03 | 46 | 25 | 2 | GO:0090505 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of cells | 1.41e-03 | 46 | 25 | 2 | GO:0044319 | |
| GeneOntologyBiologicalProcess | epiboly | 1.47e-03 | 47 | 25 | 2 | GO:0090504 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.69e-03 | 197 | 25 | 3 | GO:1902904 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.73e-03 | 51 | 25 | 2 | GO:0031111 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell migration | 1.82e-03 | 202 | 25 | 3 | GO:0010634 | |
| GeneOntologyBiologicalProcess | tRNA metabolic process | 2.00e-03 | 209 | 25 | 3 | GO:0006399 | |
| GeneOntologyBiologicalProcess | respiratory system process | 2.01e-03 | 55 | 25 | 2 | GO:0003016 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 2.16e-03 | 57 | 25 | 2 | GO:0007020 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 2.17e-03 | 1157 | 25 | 6 | GO:0006812 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 2.23e-03 | 217 | 25 | 3 | GO:1903034 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.23e-03 | 217 | 25 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 2.26e-03 | 218 | 25 | 3 | GO:1903169 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.31e-03 | 59 | 25 | 2 | GO:0085029 | |
| GeneOntologyBiologicalProcess | establishment of spindle localization | 2.55e-03 | 62 | 25 | 2 | GO:0051293 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 2.72e-03 | 64 | 25 | 2 | GO:0010171 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 2.88e-03 | 66 | 25 | 2 | GO:0007019 | |
| GeneOntologyBiologicalProcess | spindle localization | 2.97e-03 | 67 | 25 | 2 | GO:0051653 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis | 2.97e-03 | 67 | 25 | 2 | GO:0048260 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 3.15e-03 | 69 | 25 | 2 | GO:0031113 | |
| GeneOntologyBiologicalProcess | regulation of focal adhesion assembly | 3.24e-03 | 70 | 25 | 2 | GO:0051893 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction assembly | 3.24e-03 | 70 | 25 | 2 | GO:0090109 | |
| GeneOntologyBiologicalProcess | vesicle targeting | 3.33e-03 | 71 | 25 | 2 | GO:0006903 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 3.40e-03 | 866 | 25 | 5 | GO:0055082 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 3.41e-03 | 524 | 25 | 4 | GO:0009593 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 3.47e-03 | 254 | 25 | 3 | GO:0010810 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 3.55e-03 | 256 | 25 | 3 | GO:0032412 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 3.61e-03 | 74 | 25 | 2 | GO:0002011 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 3.61e-03 | 74 | 25 | 2 | GO:0010812 | |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 3.71e-03 | 75 | 25 | 2 | GO:0022617 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 3.71e-03 | 75 | 25 | 2 | GO:0150116 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 3.90e-03 | 77 | 25 | 2 | GO:0009583 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 3.95e-03 | 266 | 25 | 3 | GO:0022898 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 1.48e-05 | 5 | 26 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | basal cortex | 3.11e-05 | 7 | 26 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | chromaffin granule | 1.55e-04 | 15 | 26 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | kinetochore microtubule | 3.38e-04 | 22 | 26 | 2 | GO:0005828 | |
| GeneOntologyCellularComponent | microtubule plus-end | 5.51e-04 | 28 | 26 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | microtubule end | 1.02e-03 | 38 | 26 | 2 | GO:1990752 | |
| GeneOntologyCellularComponent | cell cortex region | 1.43e-03 | 45 | 26 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | cation channel complex | 3.01e-03 | 235 | 26 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 3.13e-03 | 67 | 26 | 2 | GO:0031093 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.70e-03 | 73 | 26 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | spindle microtubule | 5.10e-03 | 86 | 26 | 2 | GO:0005876 | |
| GeneOntologyCellularComponent | platelet alpha granule | 5.94e-03 | 93 | 26 | 2 | GO:0031091 | |
| Domain | CLASP_N_dom | 1.12e-05 | 4 | 26 | 2 | IPR024395 | |
| Domain | CLASP_N | 1.12e-05 | 4 | 26 | 2 | PF12348 | |
| Domain | Ion_trans_dom | 5.20e-04 | 114 | 26 | 3 | IPR005821 | |
| Domain | Ion_trans | 5.20e-04 | 114 | 26 | 3 | PF00520 | |
| Domain | SERPIN | 1.20e-03 | 37 | 26 | 2 | SM00093 | |
| Domain | Serpin | 1.27e-03 | 38 | 26 | 2 | PF00079 | |
| Domain | Serpin_fam | 1.34e-03 | 39 | 26 | 2 | IPR000215 | |
| Domain | HEAT | 2.02e-03 | 48 | 26 | 2 | PF02985 | |
| Domain | HEAT | 2.94e-03 | 58 | 26 | 2 | IPR000357 | |
| Domain | HEAT_REPEAT | 4.25e-03 | 70 | 26 | 2 | PS50077 | |
| Domain | EF-hand-dom_pair | 7.19e-03 | 287 | 26 | 3 | IPR011992 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 7.73e-05 | 8 | 24 | 2 | M27351 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16914514 | ||
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 5.80e-07 | 2 | 27 | 2 | 10899121 | |
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 5.80e-07 | 2 | 27 | 2 | 12837247 | |
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 5.80e-07 | 2 | 27 | 2 | 16866869 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19701196 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 15928712 | ||
| Pubmed | Involvement of human ELAC2 gene product in 3' end processing of mitochondrial tRNAs. | 1.74e-06 | 3 | 27 | 2 | 21593607 | |
| Pubmed | CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development. | 1.74e-06 | 3 | 27 | 2 | 28285824 | |
| Pubmed | Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network. | 1.74e-06 | 3 | 27 | 2 | 17543864 | |
| Pubmed | CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta. | 1.74e-06 | 3 | 27 | 2 | 16824950 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 22307330 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 10514484 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.46e-06 | 38 | 27 | 3 | 30786075 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 33587225 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 11290329 | ||
| Pubmed | CLASP1 and CLASP2 bind to EB1 and regulate microtubule plus-end dynamics at the cell cortex. | 5.80e-06 | 5 | 27 | 2 | 15631994 | |
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 5.80e-06 | 5 | 27 | 2 | 17113391 | |
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 27378169 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 31878951 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 24859005 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 23940118 | ||
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 2.60e-05 | 10 | 27 | 2 | 18854161 | |
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 23001180 | ||
| Pubmed | Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | 6.42e-05 | 100 | 27 | 3 | 36966971 | |
| Pubmed | 1.21e-04 | 21 | 27 | 2 | 36343267 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 3.80e-04 | 37 | 27 | 2 | 27565344 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.01e-04 | 186 | 27 | 3 | 33637726 | |
| Pubmed | 4.90e-04 | 42 | 27 | 2 | 23863479 | ||
| Pubmed | 5.14e-04 | 43 | 27 | 2 | 24172014 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 5.66e-04 | 499 | 27 | 4 | 22810586 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.52e-04 | 231 | 27 | 3 | 16452087 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 4.37e-03 | 566 | 27 | 3 | chr14q32 | |
| Cytoband | 11p15.4 | 6.17e-03 | 200 | 27 | 2 | 11p15.4 | |
| GeneFamily | Serpin peptidase inhibitors | 6.82e-04 | 37 | 19 | 2 | 739 | |
| GeneFamily | Olfactory receptors, family 52 | 1.19e-03 | 49 | 19 | 2 | 165 | |
| GeneFamily | EF-hand domain containing | 2.18e-02 | 219 | 19 | 2 | 863 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 1.28e-05 | 291 | 23 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.56e-05 | 433 | 23 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#1 | 1.27e-04 | 91 | 23 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500 | 1.50e-04 | 488 | 23 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 1.85e-04 | 818 | 23 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.22e-06 | 192 | 27 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-05 | 126 | 27 | 3 | f582c3ed43209dca3538e60062b3edd59bf2ad6b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.82e-05 | 149 | 27 | 3 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 163 | 27 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 168 | 27 | 3 | 19d2c763b50e7168dfa7449fc407489b055526c2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 168 | 27 | 3 | fa198bd53b2d640d9a8684783bf5ca23314caae2 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.43e-04 | 169 | 27 | 3 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-04 | 170 | 27 | 3 | 9a18756e6721980d4b6c37bb52ddfe93ca79c5ab | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.48e-04 | 171 | 27 | 3 | 61d622153b91702ef21b0efc7b9581e592b7ccea | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-04 | 171 | 27 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.48e-04 | 171 | 27 | 3 | 09b3fa120f63c411f8a0dd6bd230a9720ce83fb1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 174 | 27 | 3 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 177 | 27 | 3 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-04 | 178 | 27 | 3 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.74e-04 | 181 | 27 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 27 | 3 | eadcf90b526be8fe567267da83966c8802608030 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.95e-04 | 188 | 27 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 190 | 27 | 3 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 190 | 27 | 3 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-04 | 194 | 27 | 3 | cebd6767a1bd656aac2304d29cbbc164850562cc | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.17e-04 | 195 | 27 | 3 | 003a104daf88ea46fb6c7284f61cc3a02d0311e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-04 | 195 | 27 | 3 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | metastatic_Brain-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.17e-04 | 195 | 27 | 3 | 98a21f5e27d98384b3086034bd6f83441e2e4ef9 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.17e-04 | 195 | 27 | 3 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 196 | 27 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass | 2.24e-04 | 197 | 27 | 3 | 7190143468939cf26c069d125a5e88e4bf026299 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | afb88dd6a4c650f9e1adddf1d6da467420b9f737 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | 234c40079bfc93d7c2aa634968d801e9adfb07fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_T_naive|Bac-SEP / Disease, condition lineage and cell class | 2.27e-04 | 198 | 27 | 3 | a9a009e5eeb935232034635ad4a3c27d83c081ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | (1)_T_cell-(11)_Activated_CD4_T|(1)_T_cell / shred on Cell_type and subtype | 2.27e-04 | 198 | 27 | 3 | 4b9ad91342f622c63e476d4f6a0ae5bf282a7ef5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 198 | 27 | 3 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | 3f55be62aab9424ecf237d896ce7aae24bbbe206 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 198 | 27 | 3 | 41342dbe94d6da896669d88152c265438fa9e27d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 2.31e-04 | 199 | 27 | 3 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 2.31e-04 | 199 | 27 | 3 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_T_Cells|Trachea / Age, Tissue, Lineage and Cell class | 2.31e-04 | 199 | 27 | 3 | d5dcf7b4f58a075a7f729165556f7666e6b4c104 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | 15-Trachea-Immune|Trachea / Age, Tissue, Lineage and Cell class | 2.34e-04 | 200 | 27 | 3 | 8f1c6405de46907097e53e68e43883f21ea4f354 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 88b3646d92e126491e213f974126436cd4d04358 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.21e-04 | 61 | 27 | 2 | 0e5e74b82a61c1b544325f976fda3b217e5ce3d4 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 107 | 27 | 2 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 107 | 27 | 2 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.41e-03 | 121 | 27 | 2 | 8334a6b2ced1d6a4808458d6d4232d1b688ba28a | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.41e-03 | 121 | 27 | 2 | 4b33eeed7b70da120133b14d42c104d2461d52dc | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.41e-03 | 121 | 27 | 2 | a33e4ae0b0efb702db1b646ac0486e3b6ce48457 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 2.53e-03 | 124 | 27 | 2 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-03 | 126 | 27 | 2 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-03 | 133 | 27 | 2 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.99e-03 | 135 | 27 | 2 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-03 | 136 | 27 | 2 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | remission-multiplets|World / disease stage, cell group and cell class | 3.30e-03 | 142 | 27 | 2 | 286d01b4f95e9c0b38b91958f925f3797dffd596 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-03 | 142 | 27 | 2 | c3a5a80f78704d34db5df85d6e3e8fc84ff24268 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-03 | 144 | 27 | 2 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.43e-03 | 145 | 27 | 2 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.48e-03 | 146 | 27 | 2 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-03 | 148 | 27 | 2 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 3.57e-03 | 148 | 27 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.62e-03 | 149 | 27 | 2 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 3.62e-03 | 149 | 27 | 2 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 3.67e-03 | 150 | 27 | 2 | 0a65f5e2f4e0b0e822b029e0222b28ba2db89e6d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.67e-03 | 150 | 27 | 2 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-03 | 150 | 27 | 2 | 7bc61eb4b8c4a1909f4b7bcd1c6a88ef46102669 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-03 | 151 | 27 | 2 | 72c47ed207951e73ef6c72085b2a3f48a99be952 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-03 | 151 | 27 | 2 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-03 | 151 | 27 | 2 | 563439b0278776b82c1836c3de9fa80d1a4109af | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.77e-03 | 152 | 27 | 2 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-03 | 153 | 27 | 2 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 3.86e-03 | 154 | 27 | 2 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | Influenza_Severe-Treg|Influenza_Severe / Disease group and Cell class | 3.86e-03 | 154 | 27 | 2 | 77845bcb243aa1b1f1ca00f9ef2ae1b4d1bd3696 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_Naive|URO / Disease, Lineage and Cell Type | 3.86e-03 | 154 | 27 | 2 | 6c214ad5cbbfa8bab3f76b593cb598dfb914b566 | |
| ToppCell | severe_influenza-Treg|severe_influenza / disease group, cell group and cell class (v2) | 3.86e-03 | 154 | 27 | 2 | 25f74dfb0f0e014a232bc5318928c478480b178d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-03 | 155 | 27 | 2 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-03 | 155 | 27 | 2 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.91e-03 | 155 | 27 | 2 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.96e-03 | 156 | 27 | 2 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 3.96e-03 | 156 | 27 | 2 | d691a4defda046c1bbcb13ef38ee9abbb628c33c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-03 | 156 | 27 | 2 | d34f386985dd17293b1e320d732ab11b46be76ce | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 4.01e-03 | 157 | 27 | 2 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-03 | 157 | 27 | 2 | 10989c7046fc859f137c7cef3296508d4476f11f | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-03 | 157 | 27 | 2 | 14c4c61790eba6a388679e6d5011424d56cf3b5a | |
| ToppCell | COVID-19_Severe-PLT_3|World / Disease Group and Platelet Clusters | 4.06e-03 | 158 | 27 | 2 | b981592129cd00564a7e44e6ed43fef4585f4700 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-03 | 158 | 27 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-03 | 158 | 27 | 2 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| Drug | Cinildipine | 3.52e-05 | 56 | 26 | 3 | CID000002752 | |
| Drug | 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol | 4.49e-05 | 9 | 26 | 2 | ctd:C556295 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 5.26e-05 | 183 | 26 | 4 | 6874_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.26e-05 | 183 | 26 | 4 | 5613_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 5.96e-05 | 189 | 26 | 4 | 5587_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 2434_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 5825_DN | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 4578_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 6335_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 5408_DN | |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 3225_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3180_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3626_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 6472_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 4819_UP | |
| Drug | 1-adamantaneacetic acid | 8.22e-05 | 12 | 26 | 2 | CID000123221 | |
| Drug | o-tyrosine | 9.71e-05 | 13 | 26 | 2 | CID000091482 | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.01e-04 | 17 | 26 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | blood titanium measurement | 4.62e-04 | 36 | 26 | 2 | EFO_0021532 | |
| Disease | diabetic retinopathy (is_implicated_in) | 8.91e-04 | 50 | 26 | 2 | DOID:8947 (is_implicated_in) | |
| Disease | generalised epilepsy | 9.64e-04 | 52 | 26 | 2 | EFO_0005917 | |
| Disease | systemic scleroderma (is_marker_for) | 1.00e-03 | 53 | 26 | 2 | DOID:418 (is_marker_for) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.26e-03 | 80 | 26 | 2 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MFGFFFGRTPLIKLS | 241 | O95674 | |
| RRKFVIPDFMSFTSH | 216 | O94925 | |
| LKMTVFGAFLHRGSF | 921 | O60840 | |
| MPAFFSFMTHRFGRN | 251 | Q8NGJ3 | |
| ALFSFMTHRFGRNVP | 256 | Q8NGJ4 | |
| FFHRMMGFFFPGRSV | 2021 | Q14667 | |
| MTFPFRGSREIHHFF | 196 | Q8NH00 | |
| FTLAFRFGHTMLQPF | 466 | P11678 | |
| MARTFFAHFPLGSTL | 66 | Q8NHW6 | |
| AASRHFMKDPFLGFT | 716 | Q9C0K0 | |
| FGLFSRKVIHMFSTA | 106 | P56937 | |
| FRFSHLGPFKDATML | 356 | Q13634 | |
| FMTLLHFVASVFRGF | 4291 | Q92736 | |
| GFMPHFFRLFRSTVK | 131 | P05121 | |
| RMTFGRVFPSKARFY | 101 | A8K8P3 | |
| FDKLMHSPAGRSVFR | 91 | P49795 | |
| FTRMFADPHSKRVFS | 901 | Q7Z460 | |
| RMFADPHGKRVFSMF | 701 | O75122 | |
| PHFFFPKSRIVRSLM | 216 | P10909 | |
| LSMFHPRPFVKTRFA | 256 | Q9NZV5 | |
| TRYMFSRPFRKHGVV | 11 | P46778 | |
| TTTFFIFPNRGKMRH | 251 | Q6UXR4 | |
| KAFRLFHRIPSFGFS | 176 | Q9H777 | |
| LKARMTSFHRFFFTA | 141 | Q9BQ65 | |
| FNFFKMAVSRHLTRG | 111 | Q92994 | |
| MGTIHLFRKPQRSFF | 1 | Q6NXT4 | |
| KMSVSVNFFRPFTRF | 6 | Q7L0Y3 | |
| LRSPFMKFVAHAVSF | 381 | Q9HCX4 |